MOBBB Policy Recommendations

Please note:  these policies record the recommendations made by the South Central Priorities Committee MOBBB after consideration of the evidence review against the criteria in the South Central Ethical Framework.

Recommendations made by the Priorities Committee are passed to the constituent PCTs for a final decision regarding acceptance and implementation of each recommendation.  The PCT makes its decision after considering each recommendation in the light of their available resources and against all other calls upon those resources for all patients for whom it is responsible.

The recommendations are included on this website so that the link between the evidence review and the ethical framework can be clearly seen. 

Readers should check with each relevant PCT to confirm the policies which have been approved for implementation.  These may be found at the following links:

www.miltonkeynes.nhs.uk
www.oxfordshirepct.nhs.uk/professional-resources/priority-setting/lavender-statements/default.aspx
www.berkshire.nhs.uk/priorities
www.buckspct.nhs.uk

Date of IssuePolicy Statement
MOBBB Index of  agreed policy recommendations
Mar 2012 MOBBB Policy Recommendation 73 - Stereotactic radiosurgery for cerebral metastases
Mar 2012 MOBBB Policy Recommendation 72 - Botulinum toxin Type A for chronic headache
Mar 2012 MOBBB Policy Recommendation 71 - Extracorporeal Photopheresis (ECP) in the management of cutaneous T cell lymphoma (cTCL) and chronic graft versus host disease (cGvHD)
Feb 2012 MOBBB Policy Recommendation 70 - Fenestrated endovascular aortic stent-grafts
Feb 2012 MOBBB Policy Recommendation 69 - Facet joint injections (diagnostic)

Feb 2012

 MOBBB Policy Recommendation 68 - Facet joint injections (therapeutic)
Jan 2012 MOBBB Policy Recommendation 67 - Intravenous versus oral steroids for exacerbations of multiple sclerosis
Jan 2012 MOBBB Policy Recommendation 66 - Corticosteroid injections - patellar
Mar 2012 MOBBB Policy Recommendation 65a - Corticosteroid injections - elbow (redraft)
Jan 2012 MOBBB Policy Recommendation 65 - Corticosteroid injections - elbow
 Jan 2012 MOBBB Policy Recommendation 64 - Bisphosphonate therapy for breast cancer
Dec 2011 MOBBB Policy Recommendation 63 - Non pharmacological services for dementia patients
Dec 2011 MOBBB Policy Recommendation 62 - Dose escalation therapy with infliximab and adalimumab in people aged 6–17 years with severe active Crohn’s disease
Dec 2011 MOBBB Policy Recommendation 61 - Dose escalation therapy with infliximab and adalimumab in adult patients (18 or older) with severe Crohn’s disease
Dec 2011 MOBBB Policy Recommendation 60 - Dose escalation therapy with infliximab and adalimumab in people with active fistulising Crohn's disease
Dec 2011

MOBBB Policy Recommendation 59b - Treatment with trastuzumab in patients with locally advanced or metastatic HER2-positive breast cancer after the cancer progresses anywhere other than inside the central nervous system.
Dec 2011 MOBBB Policy Recommendation 59a - Trastuzumab for advanced HER2-positive breast cancer in patients who previously received trastuzumab for early breast cancer
Nov 2011 MOBBB Policy Recommendation 58 - Radiofrequency ablation and cryotherapy for renal tumours
Nov 2011 MOBBB Policy Recommendation 57 - Dexamethasone implant (Ozurdex®), ranibizumab (Lucentis®) and bevacizumab (Avastin®) for macular oedema caused by retinal vein occlusion (An update)
Nov 2011 MOBBB Policy Recommendation 56 - Ranibizumab (Lucentis®), bevacizumab (Avastin®), pegaptanib (Macugen®) and fluocinolone acetonide  (Iluvien®) for diabetic macular oedema (An update)
Oct 2011 MOBBB Policy Recommendation 55 - Routine follow-up after primary hip or knee replacement surgery
July 2011 MOBBB Policy Recommendation 54 - Rituximab in mantle cell lymphoma
July 2011 MOBBB Policy Recommendation 53 - Albumin-bound paclitaxel in metatastic breast cancer
July 2011 MOBBB Policy Recommendation 52 - Cetuximab in metastatic colorectal cancer
June 2011 MOBBB Policy Recommendation 51 - Surgical Treatment of Femoro-acetabular (Hip) Impingement (Arthroscopic and Open Approaches)
May 2011 MOBBB Policy Recommendation 50 - Implementation of NICE Medical Technologies Guidance (MTGs) and Diagnostic Technologies Guidance (DTGs)
May 2011 MOBBB Policy Recommendation 49 - Hip Resurfacing for advanced arthropathy
May 2011 MOBBB Policy Recommendation 48 - Treatment of patients with previously symptomatic gallstones who are now free of symptoms
May 2011 MOBBB Policy Recommendation 47a - Treatments for erectile dysfunction
May 2011 MOBBB Policy Recommendation 46 - Intravitreal Bevacizumab (Avastin) in Wet Age Related Macular Degeneration (AMD)
Apr 2011 MOBBB Policy Recommendation 45a - Biological disease modifying drugs in Rheumatoid Arthritis in adults
Apr 2011 MOBBB Policy Recommendation 44 - Trans-catheter aortic valve implantation (TAVI) for aortic stenosis
Apr 2011 MOBBB Policy Recommendation 43a - Referral for knee joint replacement revision surgery
Apr 2011 MOBBB Policy Recommendation 42a - Referral for hip joint replacement revision surgery
Mar 2011 MOBBB policy Recommendation 41 - Dose-dense temozolomide in recurrent glioblastoma multiforme
Mar 2011 MOBBB Policy Recommendation 40 - Degarelix for tumour flare prevention in prostate cancer
Jan 2011 MOBBB Policy Recommendation 39 - Pentostatin for hairy cell leukaemia
Jan 2011 MOBBB Policy Recommendation 38 - Adjuvant gemcitabine in pancreatic cancer
Jan 2011 MOBBB Policy Recommendation 37 - Primary hip joint replacement
Jan 2011 MOBBB Policy Recommendation 36 - Primary knee joint replacement
Jan 2011 MOBBB Policy Recommendation 35 - Pharmaceutical Treatment of Pulmonary Hypertension (primary & secondary)
Jan 2011 MOBBB Policy Recommendation 34 - Dabigatran for the prevention of stroke and systemic embolism in atrial fibrillation
Nov 2010 MOBBB Policy Recommendation 33 - Implementation of NICE Interventional Procedures Guidance (IPGs)
Nov 2010 MOBBB Policy Recommendation 32 - Immediate-release fentanyl for break-through cancer pain
Nov 2010 MOBBB Policy Recommendation 31 - Raltegravir in the management of human immunodeficiency virus type 1 (HIV-1) infection in adult patients
Nov 2010 MOBBB Policy Recommendation 30 - Additional contralateral (sequential) cochlear implants in profoundly deaf children
Oct 2010 MOBBB Policy Recommendation 29 - Deep brain stimulation for primary dystonia and essential tremor
Oct 2010 MOBBB Policy Recommendation 28 - Palivizumab for the prevention of serious Respiratory Syncytial Virus (RSV) disease in at risk pre-term infants
Oct 2010 MOBBB Policy Recommendation 27 - Maraviroc in the management of human immunodeficiency virus type 1 (HIV-1) infection resistant to standard therapy
Sep 2010 MOBBB Policy Recommendation 26 - Assisted Conception Services
Oct 2010 MOBBB Policy Recommendation 25 - Bexarotene for refractory cutaneous T-cell lymphoma
Oct 2010 MOBBB Policy Recommendation 24 - Plerixafor for second-line mobilisation of haematopoietic stem cells prior to autologous stem-cell transplantation in patients with (i) non-Hodgkin's lymphoma or (ii) multiple myeloma
Sep 2010 MOBBB Policy Recommendation 23 - Anti-vascular endothelial growth factor (anti-VEGF) as an adjunct to vitrectomy for proliferative diabetic retinopathy
Sep 2010 MOBBB Policy Recommendation 22 - Functional Electrical Stimulation in Drop Foot of Central Origin
Sep 2010 MOBBB Policy Recommendation 21 - Cascade-testing for familial hypercholesterolaemia
Sep 2010 MOBBB Policy Recommendation 20 - Neurosurgery for cerebral metastases
Aug 2010 MOBBB Policy Recommendation 19 - Fenestrated endovascular stent-grafts for abdominal aortic aneurysms
Aug 2010 MOBBB Policy Recommendation 18 - Robot-assisted laparoscopic radical prostatectomy
Jul 2010 MOBBB Policy Recommendation 17 - Dipeptidyl peptidase type 4 (DPP-4) inhibitors (Sitagliptin, Vildagliptin and Saxagliptin) in the management of type 2 diabetes (T2DM)
Jul 2010 MOBBB Policy Recommendation 16 - Treatment Pathway for Adults with Attention Deficit Hyperactivity Disorder (ADHD)
Jul 2010 MOBBB Policy Recommendation 15 - Atomoxetine in Adults with Attention Deficit Hyperactivity Disorder (ADHD)
Jul 2010 MOBBB Policy Recommendation 14 - Drug Treatment in Children with ADHD
Jun 2010 MOBBB Policy Recommendation 12 - Carmustine implants for glioblastoma multiforme
Jun 2010 MOBBB Policy Recommendation 11 - Bortezomib for prevention of dialysis in myeloma
May 2010 MOBBB Policy Recommendation 10 - Buprenorphine & Naloxone
Apr 2010 MOBBB Policy Recommendation 09 - Dasatinib Nilotinib for chronic myelogenous leukaemia
Apr 2010 MOBBB Policy Recommendation 08 - Zoledronic Acid
Apr 2010 MOBBB Policy Recommendation 07 - Yttrium for metastases from colorectal carcinoma
Apr 2010 MOBBB Policy Recommendation 06 - Yttrium for heptocellular carcinoma
Apr 2010 MOBBB Policy Recommendation 05 - Nab-paclitaxel
Apr 2010 MOBBB Policy Recommendation 04 - EOX
Apr 2010 MOBBB Policy Recommendation 03 - Bendamustine
Apr 2010 MOBBB Policy Recommendation 02 - Aprepitant
Apr 2010 MOBBB Policy Recommendation 01 - Alemtuzumab

→ Print this pageBookmark and Share